Pharmafile Logo
Pharmafocus logo
Advanced Search
FDA image

Pharma adverse event FDA reports are inadequate

February 5, 2015
Sales and Marketing FDA, Gilead, Solvaldi, US Institute for Safe Medication Practices, pharma, sofosbuvir

Reports of adverse drug events submitted to the FDA by pharma firms are often incomplete and lacking in detail, a …

News
Hospira image

Pfizer to buy Hospira for $17 billion

February 5, 2015
Sales and Marketing Hospira, Humira, Pfizer, acquisition, biosimilars, merger

Pfizer has struck a deal with Hospira to acquire the company in a deal worth around $17 billion. Industry analysts …

News
Amgen image

Late-stage successes for Amgen and Roche

February 5, 2015
Sales and Marketing Amgen, Bendamustine, Gazyva, Genentech, Humira, Levact, Napp, Roche, adalimumab, obinutuzumab

Roche and Amgen have both posted successful late-stage trial results that they say will contribute to their applications for regulatory …

News
GSK image

GSK blames respiratory woes as sales drop

February 5, 2015
Sales and Marketing Advair, GSK, GlaxoSmithKline, HIV, ViiV, Witty, anoro ellipta, breo, lovaza, q4, sales

GlaxoSmithKline’s respiratory business has been flagged as the key factor in the firm’s fourth quarter financial misfortunes, as its total …

News

Pfizer gets early approval for breast cancer drug

February 4, 2015
Sales and Marketing FDA, Pfizer, Xalkori (crizotinib), axitinib, bosulif, bosutinib, femara, ibrance, inlyta, letrozole, palbociclib

The FDA has shown Pfizer’s breast cancer drug Ibrance an early green light to treat patients who are at the …

News
Gilead image

Gilead sales soar on back of hepatitis drugs

February 4, 2015
Sales and Marketing Atripla, Gilead, efavirenz, emtricitabine, harvoni, lepidasvir, q4, sofosbuvir, sovaldi, tenofovi

The new blockbuster hepatitis C treatments Sovaldi and Harvoni more than doubled Gilead’s sales in the last quarter of 2014 …

News
cancer image

Half of UK population will get cancer

February 4, 2015
Research and Development, Sales and Marketing CDF, CRUK, Cancer, Jevtana, Sanofi, cabazitaxel

New figures from Cancer Research UK (CRUK) suggest that one in two people will develop cancer at some point in …

News
Merck image

Merck releases insomnia drug in US

February 4, 2015
Sales and Marketing FDA, Merck, belsomra, insomnia, orexin, suvorexant

Merck’s insomnia drug Belsomra is now available in the US to treat patients who have difficulty falling asleep or staying …

News
oliver_zuhlke

New chairman for Bayer’s Central Works Council

February 4, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Zühlke, Thomas de Win, central works council

Oliver Zühlke has succeeded Thomas de Win as chairman at the Central Works Council of Bayer as he steps down …

Appointment
Mylan image

Mylan buys into women’s health

February 3, 2015
Sales and Marketing Abbott, FDA, India, Mylan, famy care, female, women

Mylan is to acquire a number of women’s healthcare companies from Indian-based Famy Care that will build upon its 2008 …

News
Glyxambi image

Boehringer and Lilly score FDA yes for Glyxambi

February 3, 2015
Sales and Marketing Boehringer, FDA, Glyxambi, Tradjenta, empagliflozin, jardiance, lilly, linagliptin

The FDA has approved Glyxambi (empagliflozin/linagliptin), which has become the first combination of two diabetes drugs in their different classes …

News
affrezza image

Sanofi’s inhalable insulin goes on sale in US

February 3, 2015
Sales and Marketing Afrezza, FDA, Mannkind, Sanofi, US, apidra, diabetes, insulin, type 1, type 2

Sanofi has launched its inhalable insulin Afrezza in the US to control blood sugar in people with type 1 and …

News
andrew_smith

Sucampo Pharma names new CFO

February 3, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing andrew smith, sucampo

US firm Sucampo Pharmaceuticals has appointed Andrew Smith from within its ranks to fulfill the role of chief financial officer. …

Appointment

FDA fast-tracks Roche lung cancer drug

February 2, 2015
Sales and Marketing Cancer, FDA, MPDL3280A, Roche, bladder, lung, oncology, pdl1

Roche will be celebrating after its investigational cancer drug MPDL3280A has been fast-tracked by the FDA for the second time. …

News
Takeda image

Takeda scraps vaccine trial in Phase II

February 2, 2015
Research and Development, Sales and Marketing Diptheria-Tetanus-acellular Pertussis (DTaP) and Sabin inactivated poliovirus vaccine (sIPV), Rajeev Venkayya, TAK-361S, Takeda

Takeda has announced it is abandoning the development of a vaccine in Japan that was in Phase II clinical trials.TAK-361S, …

News

Sun Pharma and Ranbaxy merger gets US nod

February 2, 2015
Manufacturing and Production, Sales and Marketing India, Ranbaxy, Sun Pharma, US, generics, merger, recall, torrent

The US Federal Trade Commission has given its approval for Sun Pharma’s $4 billion acquisition of troubled Indian firm Ranbaxy …

News
Shire image

Shire drug approved for binge eating disorder

February 2, 2015
Sales and Marketing ADHD, FDA, Shire, Vyvanse, binge, eating, lisdexamfetamine dimesylate, obesity

Shire has become the first company to gain FDA approval for a treatment for binge eating disorder (BED) in adults …

News
Stephen Whitehead image

Stephen Whitehead: pharma has transformed

February 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, NHS, NICE, PPRS, Stephen Whitehead, lgbt, pharma

According to The Association of the British Pharmaceutical Industry (ABPI) the dominant issue in 2015 will be the affordability and …

Feature
samantha_bremner_pforbes

Packer Forbes Communications hires director

February 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Packer Forbes, samantha bremner

Samantha Bremner has joined healthcare comms firm Packer Forbes as an associate director and member of the agency’s leadership team.

Appointment
J&J image

J&J leukaemia drug gets FDA go-ahead

January 30, 2015
Sales and Marketing FDA, J&J, JJ, Janssen, The US Food and Drug Administration has shown Janssen’s leukaemia drug Imbruvica the green light to treat patients with waldenström’s macroglobulinemia (WM) – a rare indol, Waldenström’s Macroglobulinemia, ibrutinab, imbruvica, johnson

The US Food and Drug Administration has shown Janssen’s leukaemia drug Imbruvica the green light to treat patients with waldenström’s …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026